Drug major Dr Reddy's Laboratories has submitted a proposal to the Drugs Controller General of India (DCGI) to register Sputnik Light vaccine as a booster dose against Covid-19, a top company official has said.
The Hyderabad-based drug major had partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of Sputnik V and distribute the vaccine in India in September 2020.Last year, the company received permission from the DCGI to import the Sputnik vaccine into India for restricted use in emergency situations in April.
"As regards to Sputnik, we are now ready with capacities in India. We are working actively with the Government of India for registering Sputnik Light as a vaccine and as a booster dose of Sputnik V," Dr Reddy's Laboratories CEO Erez Israeli said in an analyst call.
The drug maker has also submitted a proposal to DCGI to conduct a trial to test Sputnik Light as a booster to other vaccines, he added, according to a news agency.